[EN] PYRAZOLOPYRIDINES AND PYRAZOLOPYRIDINES AND THEIR USE AS TYK2 INHIBITORS<br/>[FR] PYRAZOLOPYRIDINES, ET PYRAZOLOPYRIDINES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE TYK2
申请人:HOFFMANN LA ROCHE
公开号:WO2012066061A1
公开(公告)日:2012-05-24
The invention provides compounds of Formula (I), stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula (I) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy, as TYK2 Kinase inhibitors.
PYRAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
申请人:F. Hoffmann-La Roche AG
公开号:US20130252941A1
公开(公告)日:2013-09-26
The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R
1
, R
2
, R
4
and R
5
are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy.
Pyrazolopyridine compounds, compositions and methods of use
申请人:F. HOFFMANN-LA ROCHE AG
公开号:US09309240B2
公开(公告)日:2016-04-12
The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy.
申请人:Sanford Burnham Prebys Medical Discovery Institute
公开号:US10118902B2
公开(公告)日:2018-11-06
Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
A Scalable and Metal-Free Synthesis of Indazoles from 2-Aminophenones and In Situ Generated De-Boc-Protected <i>O</i>-Mesitylsulfonyl Hydroxylamine Derivatives